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The present study was conducted to investigate the eicosa-
noid metabolism of highly enriched human Langerhans cells 
and keratinocytes. Arachidonic acid (100 JiM) was added to 
the cells which were then stimulated with 1 JiM calcium 
ionophore A 23187 for 10 and 30 min. The supernatants 
were examined for cyclooxygenase and lipoxygenase prod-
ucts using different chromatographic systems and radioim-
munoassays. Compounds were identified by comparison 
with authentic standards. 
The major cyclooxygenase product of both cell types was 
prostaglandin D2 , with minor amounts of prostaglandin E2 . 
The main products of the lipoxygenase pathway were S-hy-
E icosanoids are arachidonic acid-derived products of membrane phospholipids that act as short-lived local mediators that induce a wide spectrum of biologic ac-tivities. One major pathway of arachidonic acid (AA) metabolism results in the production of prostaglan-
dins (PG) via a cyclooxygenase, the other in the generation of 
mono-HETE and leukotrienes (LT) via lipoxygenases. These di-
verse mediators exert a wide variety of biologic functions, rangmg 
from leukocyte chemotaxis and smooth muscle contraction to plate-
let homeostasis and immunomodulation. These latter activities are 
mediated by activation of both the adenylate cyclase and/or the 
phospholipase C s1gnal transduction pathways [t -4). 
For many years, peripheral blood leukocytes have been the focus 
of studies on the generation of AA-derived mediators [ 1]. More 
recently, these agents have been demonstrated in cutaneous tissue of 
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droxyeicosatetraenoic acid (5-HETE), 12-HETE, 15- HETE, 
and their corresponding hydroperoxy derivatives, with small 
amounts of leukotrienes B 4 and C 4 • The major differences in 
the metabolism of the two cell types were related to faster 
kinetics of generation of the mediators and a more complete 
conversion of arachidonic acid by the LC. Because eicosa-
noids have been implicated to be potent mediators of inflam-
mation and immunomodulators, the present data underline 
theJotential contributory role of epidermal cells to eicosa-
noi -associated pathologic processes. J luvest Dermatol 
95:104-107, 1990 
inflammatory dermatoses such as psoriasis [5,6), and their genera-
tion has been studied in epidermal cell (EC) suspensions of normal 
skin [7,8]. Elimination ofLC from the EC pools had no significant 
effect on lipoxygenase product generation, suggesting that kerati-
nocytes are the main source of chest> substances in the epidermis [7). 
In a recent publication, guinea pig LC have, however, been shown 
to generate large quantities ofPGs and 12-HETE [9]. A preliminary 
report also describes the production of PGD2 and 15-HETE by 
human LC [10]. 
Because LC are potent immunocompetent cells that resemble 
dendritic cells and macrophages in many functions [11), it seemed 
warranted to examine the relative importance of the different AA-
derived mediators from LC and keratinocytes in a more systematic 
fashion and in the human system. The present data show a faster and 
more efficient metabolism of AA by LC, underlining the potential 
role of these cells not only in immune-related, but also in inflamma-
tory processes of the epidermis. 
MATERIALS AND METHODS 
Epidermal and Langerhans Cell Isolat ion Isolated normal 
human EC were obtained by ttypsin digestion of surgical skin speci-
mens in four different experiments [12]. Viability was determined 
by trypan blue exclusion and was usually greater than 90%. Subse-
quently, EC were labeled by a direct immunofluorescent method, 
with a fluorescein isorhiocyanate (FITC)-conjugated OKT-6 
monoclonal antibody (Ortho Diagnostic Systems, Boston, MA). 
The OKT -6 antibody has previously been shown to react with 70o/o 
of human intrathymic lymphocytes and specifically with epidermal 
LC, bur not wtth other epidermal cell types [13]. The fluorescent-
activated cell sorter (FACS) was applied to isolate LC on the basis of 
positive fluorescence. A FACS IV machine (Becton Dickinson, 
Sunnyvale, CA) equipped with blue line (488 nm) at 200 mW 
power of an argon ion laser and LP-520 and colored glass filters for 
green fluorescence of FITC was used. The 80-JLm nozzle was ap-
plied, and the sample pressure was adjusted to a flow rate of 
1500-2500 cellsjs. The percentage of OKT-6(+) cells in the origi-
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nal EC suspensions w~ determined by a series of flow cytomemc 
analyses earned out on a dozen different skin samples. The EC 
analysis showed 2.0 ± O.So/o of OKT-6(+) cells. These cells were 
collected in plastic tubes filled with RPM! 1640 medium (Gibco, 
UK), and LC represented 90 ± So/o ofFACS-sorred cells, as studied 
by immunofluorescence and electron microscopy. The contammat-
ing cell population of LC-ennched suspensions consisted only of 
keratinocytes [14). 
Cell Stimulation Two cell populations were~ used for the srud1l'~ 
of eicosanoid generation, LC-enriched and LC-depleted cells (ke-
rannocytes). Both LC-enriched and LC-depleted cells were sus-
pended at 106 cellsjml in RPM I. Aliquors of 2 X 105 to 4 X 105 
cells were then incubated w1th either (1-HC) AA (NEN, Paris, 
France) (specific activity, 52 mCi/mmol; final amount added, 0.8 
JLM) and/or with unlabeled AA (1 00 JLM) in the presence of calc1um 
ionophore A 23187 at 1 JiM (Boehringer Mannheim, FRG) for I 0 
min at 37"C. The cells were then centrifuged and the supernatants 
collected. The cell pellets were resuspended in RPM I and incubated 
at 37"C for another 30 min with the same stimulants as descnbed 
above. Cells were then cenmfuged again, and the samples of both 
the 10- and 30-min supernatants were stored at -20"C until analy-
sis for AA metabolites. 
Reverse-Phase High-Perfor mance Liquid Chromatography 
(RP-HPLC) Ana lysis Cell supernatants were extracted tnto 
ethyl acetate at pH 3.0 and centrifuged at 72S X g for 3 min. The 
orgamc phase was evaporated to dryness under a stream of nitrogen 
and then resuspended in 100 jil methanol. PGB2 (200 ng/sample) 
served as internal standard. The recovery of PGB2 was determmed 
to be 84 ± 6 o/o (mean± 1 SD). RP-HPLC was performed With an 
LKB 21SO system (LKB, Freiburg, FRG}, as previously described 
(15). Briefly, a Nucleosil ODS silica column (250 X 4.6 mm, 5 Jim) 
with guard column (Bischoff, Leonberg, FRG} was used at room 
temperature. Absorption was measured at 280 nm for LT and at 237 
nm for HETE. The elution was performed at a flow rate of I 
ml/min, starring with solvent A for the first 3 min and then fol-
lowed by a linear mcrease of solvent B to 100% withm 12 mm. 
After 34 min, the column was washed with methanol. Solvent A 
contained aceton.itrile/ethanoljwater/acetic acid/phosphoric acid/ 
ammonia (25: 40:34:0.3:0.3: 0.2} (by volume), solvent B (40: 
30:29: O.S: 0.3: 0.2) (by volume). Identification was earned out 
with authentic LT, HETE, and HPETE as reference material by 
comparison of the retention times. Another isocratic system [7] was 
used for comparison with data previously obtained with mixed EC 
preparations. 
Standards were purchased from either Paesel (Frankfurt, FRG) 
(LTB4 , -COOH- LTB4 , -OH-LTB4 , 5,12- and 15-HETE and 
H PETE and S,6-diHETE) or Ultrafine Chemicals (Salford, UK) 
LTC4,D4,E4}. The LTB4 isomers were kindly provided by Dr. M. 
Haurand (Gruenenthal GmbH, Aachen, FRG). All HPLC solvents 
were of H PLC-grade and were purchased from either Merck 
(Darmstadt, FRG) or Sigma (Deisenhofen, FRG}. 
Thin-Layer C hromatography (TLC) Ana lysis The proce-
dure for sample preparation was the same as for HPLC analysis. 
PGs were analyzed by TLC at room temperature on Si60-coated 
alummum sheets (Merck, Darmstadt, FRG), using the upper 
layer of ethylacetate/2.2,4-tnmerhylpenrane/acetlc ac1djwater 
(11 0: SO: 20: 1 00) (by volume) as mobile phase over a m1gmion 
distance of IS em [16]. With standards obtained from Paescl 
(Frankfurt, FRG}, the rf values were found to be as follows: 
PGF2a=O.t9; TxB2 =0.28; PG~=0.31; PGD2 =0.47; 
H HT = 0.86. ldenrificauon was performed by comparison of rhe rf 
values with those of authentic, non-labeled standards after visual-
IZation With iodine vapor. All TLC solvenrs were of HPLC-grade 
and purchased from Merck (Darmstadt, FRG) or Sigma (Deisen-
hofen, FRG). 
Radioimmunoassays (RIA} Evaluation of crude LC and ke-
rarinocyre supernatants was done with a commercially available 
LTB. and LTC4 RIA [6,17]. H PLC fraction ofkeratinocyte and LC 
were also examined in the LTB4 RIA. 
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RESULTS 
Con vers ion of AA via the Cyclooxygenasc Pathway F1gure 
1 shows the different cyclooxygenase products separated With TLC. 
In both cell preparations, the main cyclooxygenase product was 
PG02, Wl[h minor amounts of PG~. Arachidomc ac1d conversion 
was faster and more complete 111 LC as compared to kerarinocyres. 
The amount of conversion ro PGD2 was 39% of the coral radioactiv-
Ity in LC vs !So/o in keratmocyres after 30 min of srimulauon. The 
peaks between PGD2 and AA represent the d1fferenr HETEs and 
HPETEs that are formed. The presence of PGs in the supernatants 
was confirmed with a second TLC system (as described in Ref 18; 
data not shown). 
Con version of AA via the Lipoxygcnase Pathway Figure 2 
shows the conversion of exogenous AA and ( 1-14C} AA to 1S-
HETE, 12-HETE, 5-HETE, and the corresponding HPETE by the 
lipoxygenases. An additional peak was produced with both cell 
rypes which coeluted With 9-HETE. The contribunon of 5-, 12-, 
and 15-lipoxygenase to the total amount ofHETEand HPETE was 
almost the same, with a ~light preference for the IS-lipoxygenase 
pathway. There were no qualirauve d1fferences between the genera-
non of HETE and HPETE for the two cell types studied. 
LC supernatants also yielded peaks wh1ch corresponded to L TC4 , 
L TB4 and ro ItS isomers. However, a clear resolution of the LTC4 
peaks could not be observed m all expenments. Keratinocytes gen-
erated smaller quantities ofLT a gam and fa1led to show a compound 
With the elution characteristics of L TC4 • Further confirmation of 
these data was obtained with another 1socrat1c system (as described 
in Ref7}, where metabolites coeluttng with LTB4 , its isomers, and 
the HETE could be found for both cell rypes studied. Analysis of 
crude supernatants for L TB4 and L TC4 by RIA indicated the pres-
ence of LTB4 and L TC4 in both the LC and keratinocyte superna-
tants, with LC generating more L TC4 and keratinocyte superna-
tants moreL TB4 (Table 1). The larger quantities of L TB4 formed by 
kerarinocytes as compared w1th LC were confirmed on analys1s of 
the HPLC fractions where large quanm1es of LTB4 and its two 
oc-metabolires could be measured, whereas only modest quantities 
of 20-0H-L TB4 and the L TB4 were measured in the LC fractions 
(nor shown). 
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Figure 1. Cyclooxygenase product' from Langerhans cells (LC) and kc-
rarinocytes (K) . LC and K were sumulated for !Oor 30 mm w1th (t-••q AA 
I 00 pM AA, and 1 JIM A23187, aJ. descnbed Ill Maurials and Mrthods. Cy-
clooxygenase products were separated by TLC, and Identification was per-
formed by comparison of the retention values (abscissa) With those of au-
thentic standards. The 11111nbm above the peaks give the conmbution 111 % of 
the total amount of radioacnv1ry, shown as cpm on the ordinate. 
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Figure 2. Lipoxygenase products from Langerharu cells (LC) and kera-
cinocytes (K). Cells were stimulated for 10 and 30 min. Lipoxygcnase prod-
uCtS were separated by RP-HPLC, as described in MareriaiJ and Methods. 
Wavelength settings were 280 nm for leukotrienes (0 - 22 min, ordinate) and 
237 nm for monoHETE (22-35 min) (A). Radioactivity was measured 
on-line and expressed as cpm (B). Retention times of authentic standards are 
indicated by arrow1: 1 = L TC4; 2 = PGB2; 3 = L TB4; 4 = 15-HETE; 5 = 
15-HPETE; 6 = 12-HETE; 7 = 12-HPETE; 8 = 9-HETE; 9 = 5-HETE; 
10 = 5-HPETE. 
DISCUSSION 
The present data show that both highly purified human LC and 
keratinocytcs are able to generate a wide range of cyclooxygenase 
and lipoxygenase products in vitro. The findings are supported by 
reproduction of the data with four different cell preparations and 
with different chromatographic systems. Because of the limited 
Table I. Levels ofLT, Expressed as ng/ml, in the 10 min LC 
and the 30-min Keratinocyte (K) Supernatants, as Measured by RIA. 
LC 
K 
LTB. 
0.6 ±0.1 
7.5 ±0.8 
LTC4 
16.1 ± 1.1 
2.4 ± 0.9 
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availability of human LC, obvious drawbacks of this approach were 
difficulties in quantification of the different products and statistical 
analysis of the data. 
The results show no maJor qualitative differences between LC 
and keratinocytes in rhe spectrum of AA-derived products regarding 
both the lipoxygenase and the cyclooxygenase metabolites. How-
ever, a difference was found in the LC-enriched fractions in so far as 
these cells exhibited a much higher conversion of AA toward PGD2 
and certain lipoxygenase products than keratinocytes. Although LC 
make up only a small fraction of the entire epidermal cell popula-
tion, basal epidermal cells have a much hi~her AA metabolism com-
pared with differentiating keratinocytes [19]. The contribution of 
LC to AA metabolism in the microenvironmenr of the lower and 
mid-epidermis might rhus be considerable. 
The observation that LC convert exogenous AA much more rap-
idly than keratinocytes is an intriguing finding. Since both cell types 
were provided with an ample supply of exogenous AA in the present 
experiments, the differences in AA metabolism, as observed in this 
srudy, cannot be attributed to differences of the cells in generating 
AA but rather to higher levels or activities of the enzymes involved 
in the cyclooxygenase and lipoxygenase pathways. 
The present results confirm previous findings with mixed human 
and murine EC [7 ,8,19- 22). In these studies, EC were found to 
conven AA to 5-lipoxygenase products, including LTB., irs isomers 
and LTC4 , and to additional 12- and 15-lipoxygenase products 
(7 ,8,20,22). The main metabolite generated via the cyclooxygenase 
pathway proved to be PGD2, with only minor amounts of PGE2 
[19 ,21). The present data, which show relatively large quantities of 
PGD2 and, to a lesser extent, LTC4 in the LC preparations, would 
suggest that these cells are the major source of these vasoactive and 
muscle contracting mediators in the epidermis. 
Our findings regarding the AA metabolism of LC vs keratino-
cytes are a confirmation of data regarding the cyclooxygenase but 
not the lipoxygenase pathway in the literature. Thus, Ruzicka and 
Au bock have recently reported the preferential conversion of AA to 
PGD2 in highly enriched LC of guinea pig origin, with minor 
amounts of PGE2 and 12-HETE [9]. Their LC-depleted cell frac-
tions showed a preference for 12-HETE, PGEz, and PGD2 genera-
tion from AA. Therefore, both cell types produced only one lipoxy-
genase product, with kerarinocytes being more active than LC. 
According to a preliminary communication, human LC produce 
mainly PGD2 and 15-HETE, while kerarinocyres generated mainly 
12-HETE and negligible amounts of PGD2 [10]. All these data, 
including our own, therefore agree on the fact char the main cy-
clooxygenase product of LC is PGD2, whereas they are at variance 
with regard ro the lipoxygenase products. Reasons for this diver-
gence may relate to species differences, methods employed to ob-
tain, handle and stimulate the cells, and different analytical tech-
niques used. 
The high level ofPGD2 generation by LC is intriguing. Macro-
phages and mast cells are other cell types where PGD2 is a major 
cyclooxygenase product [23). The physiologic role of PGD2 is still 
less understood than that of PGs of theE-series. In vivo, PGD2 has 
been shown to enhance L TB4-induced migration of neutrophils 
into the skin [24). It also acts as a peripheral vasodilator and aug-
ments the cAMP content of cells [2). Because an increase in intracel-
lular cAMP is believed to be an imponanr signal transduction path-
way, PGD2 might be a negative feedback regulator of the immune 
response, as is PGE2 (4). 
In conclusion, this study shows that human LC are able to gener-
ate more PGD2 and, most likely, more LTC4 than kerarinocytes. In 
addition, LC generate other cyclooxygenase and lipoxygenase 
products from AA, with a greater degree of conversion than human 
kcratinocytcs. These propenics may enable LC to provide an effi-
cient cutaneous line of defense against invading external agents by 
mounting a rapid anti-inflammatory and an immunologic response. 
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